Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
暂无分享,去创建一个
R. Paschke | L. Hegedüs | M. Eszlinger | A. Krogdahl | C. Ferraz | F. Narz | C. Rehfeld | Eva Magrethe Precht Jensen | E. Bösenberg
[1] V. Marotta,et al. The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.
[2] H. Gharib,et al. Thyroid nodule guidelines: agreement, disagreement and need for future research , 2011, Nature Reviews Endocrinology.
[3] R. Paschke,et al. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. , 2011, The Journal of clinical endocrinology and metabolism.
[4] B. Ljung,et al. Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine-needle Aspiration Biopsy , 2010, World Journal of Surgery.
[5] Matthias M. Weber,et al. Detection of Papillary Thyroid Carcinoma by Analysis of BRAF and RET/PTC1 Mutations in Fine-needle Aspiration Biopsies of Thyroid Nodules , 2010, World Journal of Surgery.
[6] R. Paschke,et al. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns , 2010, Molecular and Cellular Endocrinology.
[7] M. Brandi,et al. Thyroid Cancer: Current Molecular Perspectives , 2010, Journal of oncology.
[8] N. Eberhardt,et al. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. , 2010, Clinical chemistry.
[9] F. Pacini,et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. , 2010, The Journal of clinical endocrinology and metabolism.
[10] Xuguang Zhu,et al. Lessons from mouse models of thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[11] Yuri E Nikiforov,et al. Molecular diagnostics and predictors in thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[12] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[13] M. Nikiforova,et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. , 2009, The Journal of clinical endocrinology and metabolism.
[14] N. Eberhardt,et al. The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer , 2008, PPAR research.
[15] B. Zhu,et al. Do Benign Thyroid Nodules Have Malignant Potential? An Evidence-Based Review , 2008, World Journal of Surgery.
[16] M. Nikiforova,et al. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. , 2006, The Journal of clinical endocrinology and metabolism.
[17] S. Asa,et al. Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.
[18] Gerard M Doherty,et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2006, Thyroid : official journal of the American Thyroid Association.
[19] L. Hegedüs,et al. The Thyroid Nodule , 2004 .
[20] Y. Nikiforov,et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. , 2004, The Journal of clinical endocrinology and metabolism.
[21] P. Kastner,et al. Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.
[22] T. Dwight,et al. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. , 2003, The Journal of clinical endocrinology and metabolism.
[23] L. Sobrinho,et al. Expression of PAX8-PPARγ1 Rearrangements in Both Follicular Thyroid Carcinomas and Adenomas , 2002 .
[24] M. Nikiforova,et al. PAX8-PPAR&ggr; Rearrangement in Thyroid Tumors: RT-PCR and Immunohistochemical Analyses , 2002, The American journal of surgical pathology.
[25] G. Chiappetta,et al. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. , 2002, The American journal of pathology.
[26] C. Cheung,et al. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. , 2001, The Journal of clinical endocrinology and metabolism.
[27] V. Trovisco,et al. PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma , 2006 .
[28] L. Hegedüs,et al. Clinical practice. The thyroid nodule. , 2004, The New England journal of medicine.
[29] L. Sobrinho,et al. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas. , 2002, The Journal of clinical endocrinology and metabolism.